Data base for:

  • Conferences
  • Research funding opportunities
  • Competitions / Awards

Register for free and add any data by yourself!

Filter conferences

3rd Annual Inhalation & Respiratory Drug Delivery USA Congress

3rd Annual Inhalation & Respiratory Drug Delivery USA Congress

Join us to hear about the latest industry innovations at Oxford Global's Inhalation and Respiratory Drug Delivery USA Congress, 17 - 18 March 2020 in San Diego.


Date of beginning

Tuesday, 17 March 2020


2 days


San Diego


United States


Emily Hawkings


This email address is being protected from spambots. You need JavaScript enabled to view it.


Over 300 delegates from the inhalation, formulation and drug delivery industry representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic and research institutions. Over 20 presentations and case studies focussing on the emerging therapies and key issues in inhalation and respiratory drug delivery as well as the latest developments in medical devices and digital health products. Including 2 interactive streams: - Development and Formulation of Inhaled Therapies- Inhalation Devices and Analytics This event is co-located with the 3rd Annual Formulation and Drug Delivery USA Congress For more information, please contact This email address is being protected from spambots. You need JavaScript enabled to view it. Go Social: Join our Formulation and Drug Delivery Network on LinkedIn, follow us on Twitter @FDDCongress and join the conversation at #FDDUS19 *2020 Live Webinar*'The Design And Development Of A Connected Inhalation System To Help With Monitoring And Patient Adherence'Hosted by Paul Upham, Head, Smart Devices, GenentechWed, Jan 15, 2020 4:30 PM - 5:30 PM GMTRegister for Free: URLs:Tickets: On Tuesday March 17, 2020 at 7:30 am (ends Wednesday March 18, 2020 at 5:00 pm) Venue details:Hilton San Diego Mission Valley, 901 Camino del Rio South, San Diego, 92108, United States Price:Registration Available from: USD 720.00 Speakers: Christy Cappelletti, Director, Clinical Development, AstraZeneca, Yaping Zhu, Executive Director, Device Development & Inhalation Development, Sandoz, George Cusatis, Associate Director, Device & Digital Health, Merck, Samir Shah, Associate Director, Respiratory and Combination Regulatory Affairs, Teva, Paul Upham, Head, Smart Devices, Genentech, Larry Brown, Chief Scientific Officer & Executive Vice President, Noveome, Carlos Schuler, Chief Operating and Technical Officer, InCarda Therapeutics, Stephen Pham, Vice President Product Development, Avalyn Pharma